<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04993833</url>
  </required_header>
  <id_info>
    <org_study_id>STU-2021-0693</org_study_id>
    <nct_id>NCT04993833</nct_id>
  </id_info>
  <brief_title>Inter-Device Reliability of the NPi-300 Pupillometer</brief_title>
  <acronym>TRIPLE</acronym>
  <official_title>Inter-Device Reliability of the NPi-300 Pupillometer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NeurOptics Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the inter-device reliability between the NPi-200 and&#xD;
      NPi-300.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Paired assessments will be made on patients who are consented; and on healthy controls who&#xD;
      have verbally assented to participate. We plan to enroll 20 patients and 50 healthy controls.&#xD;
      Assessments will be made at the convenience of the patient and healthy controls. Each&#xD;
      assessment will include bilateral PLR reading within a 5 minute interval. The first&#xD;
      assessment will be completed with the NPi-200 and the second assessment will use the NPi-300.&#xD;
      The data will be entered into a CRF.&#xD;
&#xD;
      If there is a significant difference between readings from the NPi-200 and the NPi-300, we&#xD;
      will repeat the bilateral assessment in the following hour and the regularly scheduled time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pupil's reaction to light as measured by Neurological Pupil Index (NPI)</measure>
    <time_frame>1 year</time_frame>
    <description>Pupil's reaction to light as measured by Neurological Pupil Index (NPI) algorithm using pupillometer device that grades the pupil's reaction to light on a scale between 0 and 5. The Inter-device reliability is assessed using Cohen's Kappa method: values â‰¤ 0 as indicating no agreement.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Critical Illness</condition>
  <condition>Neuropathy</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients with risk of cerebral edema.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Staff/Faculty who interact with patients at the enrolling site.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NPi-200 and NPi-300 pupillometers</intervention_name>
    <description>Device which measures PLR.</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient Cohort: Patients admitted with a neurological or neurosurgical diagnosis that place&#xD;
        them at risk for cerebral edema.&#xD;
&#xD;
        Healthy Cohort: Faculty/Staff who interact with patients at the enrolling site&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (Patient Cohort):&#xD;
&#xD;
          -  Subjects will be included if they are adults (&gt;18 years of age) and have a&#xD;
             neurological or neurosurgical diagnosis that place them at risk for cerebral edema.&#xD;
             Subjects also have to be admitted to the enrolling site. Persons consenting for the&#xD;
             study (whether patient or LAR) will need to be able to consent for the study in&#xD;
             English.&#xD;
&#xD;
        Exclusion Criteria (Patient Cohort):&#xD;
&#xD;
          -  Patients that will be excluded from the study are those that are prisoners, under 18&#xD;
             years of age, or pregnant women.&#xD;
&#xD;
        Inclusion Criteria (Healthy Control Cohort):&#xD;
&#xD;
          -  Staff in the enrolling site&#xD;
&#xD;
        Exclusion Criteria (Healthy Control Cohort):&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DaiWai M Olson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DaiWai M Olson, PhD</last_name>
    <phone>214-648-8946</phone>
    <email>DaiWai.Olson@UTSouthwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sonja Stutzman, PhD</last_name>
    <phone>214-648-6719</phone>
    <email>Sonja.Stutzman@UTSouthwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clements University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DaiWai M Olson, PhD</last_name>
      <phone>214-648-8946</phone>
      <email>DaiWai.Olson@UTSouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sonja Stutzman, PhD</last_name>
      <phone>2146486719</phone>
      <email>Sonja.Stutzman@UTSouthwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>DaiWai M Olson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>July 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>DaiWai Olson</investigator_full_name>
    <investigator_title>Director of Neuroscience Nursing Research Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

